A NARRATIVE REVIEW ON BIOLOGICS IN THE MANAGEMENT OF ASTHMA: ASSESSING THE CURRENT LANDSCAPE.
Monoclonal antibodies (mAbs) play a crucial role in the treatment of severe asthma. Physicians rely on patient-specific characteristics to determine the appropriate asthma classification for treatment. Currently, there are five biological agents designed to target the 'TH2-high' asthma phe...
Saved in:
Main Author: | Santanu Kumar Ghosh (Author) |
---|---|
Format: | Book |
Published: |
Student's Journal of Health Research,
2023-12-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The Current Clinical Trial Landscape for Hidradenitis Suppurativa: A Narrative Review
by: Amanda Hunt, et al.
Published: (2023) -
Omalizumab and mepolizumab in the landscape of biological therapy for severe asthma in children: how to choose?
by: Mattia Giovannini, et al.
Published: (2019) -
The landscape of 'podoplanin' in dermatology: a narrative review
by: Nagwa Diab, et al.
Published: (2021) -
Pediatric airway management: A narrative review of the current practices and challenges
by: Annu Choudhary, et al.
Published: (2024) -
Premature ejaculation - current concepts in the management: A narrative review
by: Arkiath Veettil Raveendran, et al.
Published: (2021)